XenTech is a contract research organization dedicated to translational research in oncology. It offers preclinical services to evaluate the anti-cancer potential of drug candidates. In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.